| 000 | 00852nam a2200277Ia 4500 | ||
|---|---|---|---|
| 003 | sesosld | ||
| 005 | 20140128091248.0 | ||
| 008 | 080226s9999 xx 000 0 und d | ||
| 040 | _aSipr | ||
| 041 | _aeng | ||
| 100 | _aCooper, David E | ||
| 245 |
_aContract management : DOD's anthrax vaccine manufacturer will continue to need financial assistance _h[electronic resource] |
||
| 260 |
_aWashington, DC _c2000 |
||
| 300 | _a5 p. | ||
| 490 | _aGAO testimony, GAO/T-NSIAD-00-140 | ||
| 651 |
_aUSA _xBW _xterrorism _xprotection |
||
| 651 |
_aUSA _xvaccine _xcosts |
||
| 651 |
_aUSA _xmedicine _xdefence contracts |
||
| 651 |
_aUSA _xofficial publication |
||
| 653 | _aanthrax | ||
| 710 | _aGeneral Accounting Office, GAO | ||
| 852 | _hOnline resource GAO | ||
| 856 | _uhttp://www.gao.gov/browse/date/week | ||
| 942 | _cEPER | ||
| 946 | _a0004 | ||
| 999 |
_c20591 _d20591 |
||